RecruitingNot ApplicableNCT06918067

Comparison of Urinary Flow Study

Comparison of Urinary Flow Speed Using 14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter Versus 14 Fr Coloplast Micro Zone Luja Female Catheter in Female Patients Using Intermittent Catheters


Sponsor

Wake Forest University Health Sciences

Enrollment

17 participants

Start Date

Nov 6, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to compare the urinary flow speed of two different female catheters in patients that use intermittent catheters to empty their bladder. The "14 Fr Two Eyelet Coloplast Female SpeediCath Urinary Catheter" will be compared to the "14 Fr Coloplast Micro Zone Luja Female Catheter." Participants will have one study visit that should take about an hour and will also receive a follow-up telephone call about one week after the visit.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria4

  • Female
  • Regular use of intermittent catheters to empty bladder, for at least 1 month before enrolment
  • Age 18 years or older
  • Required to adhere to the intervention procedure and not participate in any other clinical studies throughout the duration of this study

Exclusion Criteria6

  • Severe urinary tract abnormalities (e.g. excessive production of urinary mucus/sediments/debris)
  • Hypersensitive to the ingredients in the catheters being tested
  • Recent surgery, within 3 months
  • Currently being treated for urinary tract infection
  • Being pregnant or breastfeeding
  • Non-English speaking

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEColoplast Micro Zone Luja Female Catheter

clean self-catheterization with 14 Fr Coloplast micro zone Luja female urinary catheter

DEVICEColoplast SpeediCath Female Catheter

clean self-catheterization with 14 Fr two eyelet Coloplast SpeediCath female urinary catheter


Locations(1)

Women's Center for Pelvic Health (Mercy)

Charlotte, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06918067


Related Trials